CBD gel shows promise for fragile x behavior issues in major trial
Symptom relief
Completed
This study tested a CBD gel (ZYN002) applied to the skin in children, teens, and young adults with Fragile X Syndrome. The goal was to see if it could ease difficult behaviors like irritability and social withdrawal. 215 participants received either the gel or a placebo for up to…
Phase: PHASE3 • Sponsor: Zynerba Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated May 14, 2026 12:06 UTC